However, the study design was limited to MS lesions localized to the spinal cord and did not examine the contribution of SIRT1 overexpression in ameliorating ocular disease manifestations.24 Potential neuroprotective effects of SIRT1 overexpression specifically in RGCs need to be examined. Here, SIRT1 is linked to myeloid sarcoma.